Transfer Learning with Multi-Sequence MRI for Segmentation of Autosomal Dominant Polycystic Kidney Disease Using U-Net
Open Access
- 16 May 2024
- journal article
- research article
- Published by MDPI AG in Electronics
- Vol. 13 (10) , 1950
Abstract
In recent studies, the measurement of total kidney volume, a primary indicator for the diagnosis and treatment of renal diseases, has been advanced through artificial-intelligence-driven automated segmentation. However, the limited quantity of medical data remains a persistent challenge, with its scarcity negatively impacting the outcomes of machine learning algorithms. In this study, we have enhanced the accuracy of machine learning for disease diagnosis by employing various MRI sequences commonly used during renal imaging. We created a model for kidney segmentation using U-Net and performed single training, joint training, and transfer learning using MRI images from two sequences based on SSFP and SSFSE. Ultimately, during transfer learning, we achieved the highest accuracy with a Dice coefficient of 0.951 and a mean difference of 2.05% (−3.47%, 7.57%) in Bland–Altman analysis for SSFP. Similarly, for SSFSE, we obtained a Dice coefficient of 0.952 and a mean difference of 4.33% (−7.05%, 15.71%) through Bland–Altman analysis. This demonstrates our ability to enhance prediction accuracy for each sequence by leveraging different sequences.Keywords
Funding Information
- Ministry of Oceans and Fisheries (20210695)
This publication has 14 references indexed in Scilit:
- Ensemble U‐net‐based method for fully automated detection and segmentation of renal masses on computed tomography imagesMedical Physics, 2020
- Autosomal dominant polycystic kidney diseaseThe Lancet, 2019
- The importance of total kidney volume in evaluating progression of polycystic kidney diseaseNature Reviews Nephrology, 2016
- Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic EfficacyAmerican Journal of Kidney Diseases, 2015
- Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2015
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2012
- I. Using the Bland–Altman method to measure agreement with repeated measuresBritish Journal of Anaesthesia, 2007
- Volume Progression in Polycystic Kidney DiseaseNew England Journal of Medicine, 2006
- The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: Recent advancesAmerican Journal of Kidney Diseases, 1996
- Autosomal dominant polycystic kidney disease in childhood: A longitudinal studyKidney International, 1987